Internal link ProQR Investor/Analyst Webcast: Lilly Partnership Expansion and Axiomer Overview Webcast With the announcement of the expansion of ProQR and Lilly's partnership, ProQR Management is hosting a conference call. Add ProQR Investor/Analyst Webcast: Lilly Partnership Expansion and Axiomer Overview to calender Investor Dec 22 2022 8:15 AM EST/14:15 CET
Internal link Investor Call Webcast ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs - Management Call Add Investor Call to calender Investor Aug 11 2022 8:15 AM EDT/14:15 CET
Internal link Annual General Meeting Presentation ProQR's 2022 Annual General Meeting (AGM) of Shareholders will take place on Thursday, June 30, 2022 at 14:00 CET (08:00am EDT) via videoconference. Add Annual General Meeting to calender Investor Jun 30 2022 8:00 AM EDT/14:00 CET
Internal link Life Sci 2nd Annual Genetic Medicines Symposium Webcast ProQR's participation in the Life Sci 2nd Annual Genetic Medicines Symposium Add Life Sci 2nd Annual Genetic Medicines Symposium to calender Investor Jun 29 2022 10:00am EDT
Internal link Conference call additional sepofarsen analyses and company strategy update Webcast ProQR shared additional analyses from the Phase 2/3 Illuminate trial of sepofarsen for LCA10 and provided an update on the company strategy. Management to host a conference call today at 8:00am EDT (14:00 CET). Add Conference call additional sepofarsen analyses and company strategy update to calender Investor Apr 13 2022 8:00am EDT / 14:00 CET